Animal trial safeguard of corona vaccine of this Indian company, agreement with American Pharma. The world’s largest forma companies are involved in making the Corona vaccine. Now Indian company Panacea Biotec has joined hands with American company Refana Inc to make Corona virus vaccine. Panacea Biotech has provided this information in the regulatory.
This partnership between the two companies has been aimed at creating an inactivated virus based vaccine. This Indian company, along with Refana, wants to make more than 50 crore doses of the potential vaccine for covid-19, with a target of supplying more than 40 million doses by next year.
In this regard, Panacea Biotech Managing Director Rajesh Jain said that the world needs a safe and effective vaccine that can be produced on a large scale in existing manufacturing facilities and meet global demand.
As part of the partnership, Panacea Biotec will be responsible for product development and commercial manufacturing, while the joint venture entity will work on clinical development and regulatory submissions. A 50-50 stake in this vaccine has been fixed between the two companies.
Rajesh Jain told a channel that the animal trial of this vaccine has been done, which is safe and effective so far. He told that between August and September, applications will be made to the Drug Authority for human trials.Panacea Biotech plans that Phase-I of Human Trial will be started in October. In addition, the company will start production of the vaccine as well. The target is to produce a dose of 40 million vaccines every month in December – 2020 and January – 2021. From storage to transportation of this vaccine will be very easy.